When to stop GnRH analog therapy: The experience of the italian study group for physiopathology of puberty

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue SUPPL. 1, 2000, Pages 759-764

  Arrigo, T ^a   Cisternino, M ^a   Galluzzi, F ^a   Bertelloni, S ^a   Pasquino, A M ^a   Antoniazzi, F ^a   Borrelli, P ^a   Crisafulli, G ^a   Wasniewska, M ^a   De Luca, F ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Central precocious puberty; Final height; Gonadotropin releasing hormone agonists; Idiopathic early puberty

Indexed keywords

GONADORELIN; TRIPTORELIN;

BODY HEIGHT; CATCH UP GROWTH; CHILD; CONFERENCE PAPER; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PRECOCIOUS PUBERTY; PROGNOSIS; PUBERTY; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0033857746     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2000.13.s1.759     Document Type: Conference Paper

References (23)

1. Analysis of the factors affecting the auxological reponse to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty
2. Effect of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty
3. Advances in the management of precocious puberty
4. Precocious puberty
5. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-Trp-6-LHRH
6. Final heights in girls with central precocious puberty following GnRH agonist-induced pituitary-gonadal suppression
7. Adult height in precocious puberty after long-term treatment with deslorelin
8. Tables for predicting adult height from skeletal age: Revised for use with the Greulich-Pyle hand standards
9. Standards for children's heights at age 2-9 years allowing for height of parents
10. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty
11. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females
12. Final height in girls with central precocious puberty: Comparison of two different luteinizing hormone-releasing hormone agonist treatments
13. Adult height in girls with idiopathic true precocious puberty
14. Long term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years
15. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist
16. Langzeittherapie mit dem retard-LHRH-agonisten Decapeptyl-depot bei Madchen mit Pubertas praecox vera
17. Growth, bone maturation, and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl depot in children with central precocious puberty
18. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy
19. Timing for discontinuation of treatment with a long-acting gonadotropin-releasing hormone analog in girls with central precocious puberty. TAP-144SR CPP Study Group
20. Final height in girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogs
21. Precocious Puberty